Table 2.
Achievement of third UNAIDS Target (viral suppression). Demographic and immunological characteristics of patients who started ART.
| Pts in ART n= 467 n (%) |
Achieved n= 383 n (%) |
Not achieved n= 84 n (%) |
p | Odds Ratio (95%CI) | |
|---|---|---|---|---|---|
| Nationality | |||||
| Italians | 290 (62) | 240 (62.6) | 50 (59.5) | 0.72 | 0.91(0.53–1.55) |
| Foregneirs | 177 (38) | 143 (37.3) | 34 (40.5) | Reference cat. | |
| Gender | |||||
| Male | 360 (77) | 295 (77) | 65 (77.4) | 0.77 | 1.09(0.59–1.99) |
| Female | 107 (33) | 88 (23) | 19 (22.6) | Reference cat. | |
| Age | |||||
| <25 yrs | 39 (8.4) | 27 (7) | 12 (14.3) | 0.11 | Reference cat. |
| 25–50 yrs | 344 (73.7) | 287 (75) | 57 (67.9) | 0.04* | 2.24(1.06–4.37) |
| >50 yrs | 84 (18) | 69 (18) | 15 (17.9) | 0.12 | 2.06(0.82–5.15) |
| CD4 cells/ml | |||||
| < 200 | 181 (38.7) | 145 (37.9) | 36(42.9) | 0.85 | Reference cat.) |
| 200–350 | 83 (17.8) | 70 (18.3) | 13(15.5) | 0.82 | 0.88(0.29–2.69) |
| 350–500 | 178 (38.4) | 148 (38.6) | 30 (35.7) | 0.77 | 1.18(0.37–3.78) |
| >500 | 25 (5.3) | 20 (5.2) | 5 (6) | 0.82 | 1.13(0.39–3.29) |
| HIVRNAcp/ml > 500.000 | 94 (20) | 80 (20.8) | 14 (16.7) | 0.29 | 1.40(0.74–2.68) |
| CDC C | 98 (21) | 78 (20.4) | 20 (23.8) | 0.81 | 0.92(4.68–1.81) |
Legend: ART: antiretroviral therapy; Pts: patients; yrs: years; cp/ml: copies/ml.